Blase N Polite

Summary

Affiliation: University of Chicago
Country: USA

Publications

  1. pmc Interventions to improve care related to colorectal cancer among racial and ethnic minorities: a systematic review
    Keith Naylor
    Section of Gastroenterology, Department of Medicine, University of Chicago, Chicago, IL, USA
    J Gen Intern Med 27:1033-46. 2012
  2. pmc Unsupported off-label chemotherapy in metastatic colon cancer
    Jonas A de Souza
    Section of Hematology Oncology, The University of Chicago Medicine, Chicago, IL, USA
    BMC Health Serv Res 12:481. 2012
  3. doi request reprint Exploring racial differences in outcome and treatment for metastatic colorectal cancer: results from a large prospective observational cohort study (BRiTE)
    Blase N Polite
    Section of Hematology Oncology, Department of Medicine, University of Chicago, Chicago, Illinois 60637 1470, USA
    Cancer 118:1083-90. 2012
  4. ncbi request reprint Colorectal cancer and race: understanding the differences in outcomes between African Americans and whites
    Blase N Polite
    Section of Hematology Oncology, Department of Medicine, The University of Chicago Medical Center, 5841 South Maryland Avenue, MC 2115, Chicago, IL 60637 1470, USA
    Med Clin North Am 89:771-93. 2005
  5. ncbi request reprint Are venous thromboembolic events associated with subsequent breast and colorectal carcinoma diagnoses in the elderly? A case-control study of Medicare beneficiaries
    Blase N Polite
    Section of Hematology Oncology, Department of Medicine, University of Chicago, IL 60637, USA
    Cancer 106:923-30. 2006
  6. ncbi request reprint Colorectal cancer model of health disparities: understanding mortality differences in minority populations
    Blase N Polite
    Section of Hematology Oncology, Department of Medicine, The University of Chicago, Chicago, IL, USA
    J Clin Oncol 24:2179-87. 2006
  7. doi request reprint Racial differences in clinical outcomes from metastatic breast cancer: a pooled analysis of CALGB 9342 and 9840--Cancer and Leukemia Group B
    Blase N Polite
    The University of Chicago Medical Center, 5841 South Maryland Ave, MC 2115, Chicago, IL 60637 1470, USA
    J Clin Oncol 26:2659-65. 2008
  8. ncbi request reprint Breast cancer and race: a rising tide does not lift all boats equally
    Blase N Polite
    Section of Hematology Oncology, Department of Medicine, University of Chicago, IL 60637, USA
    Perspect Biol Med 48:S166-75. 2005
  9. pmc Molecular analysis of colorectal tumors within a diverse patient cohort at a single institution
    BROOKE E SYLVESTER
    Center for Clinical Cancer Genetics and Global Health, Department of Medicine, The University of Chicago, Chicago, IL 60637, USA
    Clin Cancer Res 18:350-9. 2012
  10. doi request reprint Dasatinib in previously treated metastatic colorectal cancer: a phase II trial of the University of Chicago Phase II Consortium
    Manish R Sharma
    Section of Hematology Oncology, University of Chicago, 5841 S Maryland Avenue, MC 2115, Chicago, IL 60637 1470, USA
    Invest New Drugs 30:1211-5. 2012

Detail Information

Publications14

  1. pmc Interventions to improve care related to colorectal cancer among racial and ethnic minorities: a systematic review
    Keith Naylor
    Section of Gastroenterology, Department of Medicine, University of Chicago, Chicago, IL, USA
    J Gen Intern Med 27:1033-46. 2012
    ..To systematically review the literature to identify interventions that improve minority health related to colorectal cancer care...
  2. pmc Unsupported off-label chemotherapy in metastatic colon cancer
    Jonas A de Souza
    Section of Hematology Oncology, The University of Chicago Medicine, Chicago, IL, USA
    BMC Health Serv Res 12:481. 2012
    ..Newer systemic therapies have the potential to decrease morbidity and mortality from metastatic colorectal cancer, yet such therapies are costly and have side effects. Little is known about their non-evidence-based use...
  3. doi request reprint Exploring racial differences in outcome and treatment for metastatic colorectal cancer: results from a large prospective observational cohort study (BRiTE)
    Blase N Polite
    Section of Hematology Oncology, Department of Medicine, University of Chicago, Chicago, Illinois 60637 1470, USA
    Cancer 118:1083-90. 2012
    ..In this analysis, the authors examined racial differences in clinical outcomes among patients with metastatic colorectal cancer (mCRC) who received bevacizumab...
  4. ncbi request reprint Colorectal cancer and race: understanding the differences in outcomes between African Americans and whites
    Blase N Polite
    Section of Hematology Oncology, Department of Medicine, The University of Chicago Medical Center, 5841 South Maryland Avenue, MC 2115, Chicago, IL 60637 1470, USA
    Med Clin North Am 89:771-93. 2005
    ..The task now becomes to continue to understand the reasons for the disparities and ultimately to come up with workable solutions so that the amazing progress in CRC treatment benefits all groups in this country...
  5. ncbi request reprint Are venous thromboembolic events associated with subsequent breast and colorectal carcinoma diagnoses in the elderly? A case-control study of Medicare beneficiaries
    Blase N Polite
    Section of Hematology Oncology, Department of Medicine, University of Chicago, IL 60637, USA
    Cancer 106:923-30. 2006
    ..Multiple epidemiologic studies have reported associations between venous thromboembolic events and subsequent cancer diagnoses, but the published results have not suggested clear cancer screening approaches...
  6. ncbi request reprint Colorectal cancer model of health disparities: understanding mortality differences in minority populations
    Blase N Polite
    Section of Hematology Oncology, Department of Medicine, The University of Chicago, Chicago, IL, USA
    J Clin Oncol 24:2179-87. 2006
    ..Finally, areas of ongoing and future research and policy initiatives aimed at reducing disparities are discussed...
  7. doi request reprint Racial differences in clinical outcomes from metastatic breast cancer: a pooled analysis of CALGB 9342 and 9840--Cancer and Leukemia Group B
    Blase N Polite
    The University of Chicago Medical Center, 5841 South Maryland Ave, MC 2115, Chicago, IL 60637 1470, USA
    J Clin Oncol 26:2659-65. 2008
    ..This study examines racial differences in clinical outcomes in the setting of two large cooperative group randomized clinical trials...
  8. ncbi request reprint Breast cancer and race: a rising tide does not lift all boats equally
    Blase N Polite
    Section of Hematology Oncology, Department of Medicine, University of Chicago, IL 60637, USA
    Perspect Biol Med 48:S166-75. 2005
    ..This paper discusses the factors that may contribute to differences in survival and differences in stage at diagnosis between African American and white women...
  9. pmc Molecular analysis of colorectal tumors within a diverse patient cohort at a single institution
    BROOKE E SYLVESTER
    Center for Clinical Cancer Genetics and Global Health, Department of Medicine, The University of Chicago, Chicago, IL 60637, USA
    Clin Cancer Res 18:350-9. 2012
    ....
  10. doi request reprint Dasatinib in previously treated metastatic colorectal cancer: a phase II trial of the University of Chicago Phase II Consortium
    Manish R Sharma
    Section of Hematology Oncology, University of Chicago, 5841 S Maryland Avenue, MC 2115, Chicago, IL 60637 1470, USA
    Invest New Drugs 30:1211-5. 2012
    ..Dasatinib, an oral inhibitor of Src family kinases, inhibits proliferation in CRC cell lines and has antitumor activity in CRC xenograft models...
  11. doi request reprint Triple-negative breast cancers: a view from 10,000 feet
    Mandira Ray
    Section of Hematology Oncology, Department of Medicine, University of Chicago, Chicago, IL, USA
    Cancer J 16:17-22. 2010
    ..Variations in risk factors and socioeconomic status, lack of treatment, delays in treatment, and inadequate dosing of chemotherapy are just a few of the many reasons that may explain why this incidence and survival disparity persists...
  12. ncbi request reprint Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer
    James J Dignam
    Department of Health Studies, 5841 South Maryland Ave, MC 2007, University of Chicago, Chicago, IL 60637, USA
    J Natl Cancer Inst 98:1647-54. 2006
    ..We investigated the association of body mass index (BMI) with outcomes after colon cancer in patients from cooperative group clinical trials...
  13. ncbi request reprint Infused chemotherapy use in the elderly after patent expiration
    Rena M Conti
    The University of Chicago, IL 60637, USA
    Am J Manag Care 18:e173-8. 2012
    ..The use of anticancer drugs (chemotherapies) is an important determinant of national spending trends. Recent policies have aimed to accelerate generic entry among chemotherapies to generate cost savings...
  14. ncbi request reprint Combination therapy of imatinib mesylate and interferon-alpha demonstrates minimal activity and significant toxicity in metastatic renal cell carcinoma: results of a single- institution phase II trial
    Blase N Polite
    Section of Hematology Oncology, Department of Medicine, University of Chicago, IL 60637, USA
    Clin Genitourin Cancer 4:275-80. 2006
    ..Imatinib mesylate inhibits PDGF-mediated signal transduction and might thus have antiangiogenic activity as well...